High rates of transmitted NNRTI resistance among persons with acute HIV infection in Malawi: implications for first-line dolutegravir scale-up
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-6405
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
High rates of transmitted NNRTI resistance among persons with acute HIV infection in Malawi: implications for first-line dolutegravir scale-up ; volume:16 ; number:1 ; day:22 ; month:2 ; year:2019 ; pages:1-4 ; date:12.2019
AIDS research and therapy ; 16, Heft 1 (22.2.2019), 1-4, 12.2019
- Creator
-
Rutstein, Sarah E.
Chen, Jane S.
Nelson, Julie A. E.
Phiri, Samuel
Miller, William C.
Hosseinipour, Mina C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12981-019-0220-8
- URN
-
urn:nbn:de:101:1-2019032022363739148992
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rutstein, Sarah E.
- Chen, Jane S.
- Nelson, Julie A. E.
- Phiri, Samuel
- Miller, William C.
- Hosseinipour, Mina C.
- SpringerLink (Online service)
Other Objects (12)
Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil
Human resources requirements for highly active antiretroviral therapy scale-up in Malawi
Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi
A national survey of the prevalence of schistosomiasis and soil transmitted helminths in Malaŵi
Dolutegravir: Nutzenbewertung gemäß § 35a SGB V
Bioreaktoren, Scale-up
Cost-Utility Analysis of Dolutegravir- Versus Efavirenz-Based Regimens as a First-Line Treatment in Adult HIV/AIDS Patients in Ethiopia
Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
Creation of a long-acting nanoformulated dolutegravir
Unlocking the potential: exploring the impact of dolutegravir treatment on body mass index improvement in underweight adults with HIV in Malawi
Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report
Sexually transmitted infections and sexually transmitted diseases
Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil
Human resources requirements for highly active antiretroviral therapy scale-up in Malawi
Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi
A national survey of the prevalence of schistosomiasis and soil transmitted helminths in Malaŵi
Dolutegravir: Nutzenbewertung gemäß § 35a SGB V
Bioreaktoren, Scale-up
Cost-Utility Analysis of Dolutegravir- Versus Efavirenz-Based Regimens as a First-Line Treatment in Adult HIV/AIDS Patients in Ethiopia
Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
Creation of a long-acting nanoformulated dolutegravir
Unlocking the potential: exploring the impact of dolutegravir treatment on body mass index improvement in underweight adults with HIV in Malawi
Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report
Sexually transmitted infections and sexually transmitted diseases
Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil
Human resources requirements for highly active antiretroviral therapy scale-up in Malawi
Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi
A national survey of the prevalence of schistosomiasis and soil transmitted helminths in Malaŵi
Dolutegravir: Nutzenbewertung gemäß § 35a SGB V
Bioreaktoren, Scale-up
Cost-Utility Analysis of Dolutegravir- Versus Efavirenz-Based Regimens as a First-Line Treatment in Adult HIV/AIDS Patients in Ethiopia
Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
Creation of a long-acting nanoformulated dolutegravir
Unlocking the potential: exploring the impact of dolutegravir treatment on body mass index improvement in underweight adults with HIV in Malawi
Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report